Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA for Pain and Inflammation Post-Glaucoma Surgery
NCT05116345Phase 4Unknown
- Start
- Nov 2021
- Primary completion
- Nov 2023
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in postoperative pain, post-operative inflammation. Status: unknown.
02
Drugs
ozurdex
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT05116345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05116345.